News

12 Things You Need to Know About the FMCSA Clearinghouse

The Federal Motor Carrier Safety Administration (FMCSA) Drug & Alcohol Clearinghouse is a critical tool for the commercial transportation industry. It helps improve safety by tracking drug and alcohol violations for drivers with commercial driver’s licenses (CDLs) and commercial learner’s permits (CLPs). 

Common Issues to Watch Out for When Managing a DOT Random Drug and Alcohol Testing Program

For employers regulated by the Federal Motor Carrier Safety Administration (FMCSA), a compliant random drug and alcohol testing program is a required part of operating a safety-sensitive workforce. The rules are clear in principle. Drivers must be randomly selected for testing each year at the rates set by FMCSA. In practice, employers often encounter challenges that can affect compliance if the program is not carefully managed. 

Recognizing Excellence in Public Transportation Safety

It’s that time of year again where we spotlight the champions of safety across Canada! We’re thrilled to announce that, for the third year in a row, we’re partnering with Canadian Occupational Safety to present the DriverCheck Award for Canada’s Safest Public Transportation Employer at the 16th Annual Canada’s Safest Employers Awards on October 22, 2026!  

Fitness for Duty Summit 2026: Save the Date!

Get ready for the 9th Annual Fitness for Duty Summit (FFDS), a premier national event where forward-thinking leaders unite to build healthier and safer workplaces across Canada. DriverCheck welcomes operations leaders, health and safety executives and advisors, occupational health professionals, human resources and labour leaders, and regulatory decision-makers from all safety-sensitive industries including transportation, oil and gas, aviation, rail, mining, construction, healthcare, manufacturing, forestry and more! 

U.S. Federal Marijuana Policy Update: What Employers Should Know

On December 18, 2025, U.S. President Donald Trump signed an executive order directing U.S. federal authorities to reclassify marijuana from a Schedule I to a less restrictive Schedule III controlled substance under U.S. federal law. This is a significant shift in long-standing U.S. federal drug policy, but it does not currently affect any DOT testing protocols.